Ketamine vs Hydromorphone
Brief Summary
Condition or Disease
- Laparoscopic Gastric Bypass
- Obesity
- Pain, Postoperative
Phase
Study Design
| Study type: | Interventional |
|---|---|
| Status: | Completed |
| Study results: | No Results Available |
| Age: | 18 Years to 65 Years (Adult, Older Adult) |
| Enrollment: | 55 () |
| Funded by: | Other |
Masking |
|
Clinical Trial Dates
| Start date: | Feb 22, 2017 | |
|---|---|---|
| Primary Completion: | Dec 21, 2018 | |
| Completion Date: | Dec 21, 2018 | |
| Study First Posted: | Dec 23, 2016 | |
| Results First Posted: | Aug 31, 2020 | |
| Last Updated: | Dec 26, 2018 |
Sponsors / Collaborators
Location
The study will be a head to head observational study of patients who have undergone gastric bypass surgery. The methods of intraoperative anesthesiology will be Ketamine or Narcotic. Both are FDA approved methods of delivering anesthesia.
The amount of narcotics a patient receives is part of the medical record post-operatively will be followed from post-anesthesia care unit (PACU) through to discharge. The amount of narcotics needed to control the patient's pain (converted to morphine equivalent units) and pain scores (a hospital standard measure) will be collected for 48 hours for the study, or until discharge, whichever occurs sooner. The conversion to a morphine equivalent unit allows investigators to compare different narcotics the patient may receive in a more standardized way. The results will be analyzed and compared between the two groups.
Eligibility Criteria
| Sex: | All |
|---|---|
| Minimum Age: | 18 |
| Maximum Age: | 65 |
More Details
| NCT Number: | NCT03001843 |
|---|---|
| Other IDs: | IRB201500836 -A |
| Study URL: | https://ClinicalTrials.gov/show/NCT03001843 |